Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in breast sonography.

B D Fornage1

  • 1Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston 77030 USA.

JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Accuracy and Scope of Intraoperative Transoral Ultrasound and Transoral Ultrasound-Guided Fine-Needle Aspiration of Retropharyngeal Masses.

AJNR. American journal of neuroradiology·2019
Same author

The case for ultrasound of muscles and tendons.

Seminars in musculoskeletal radiology·2001
Same author

Radiofrequency ablation of solid tumors.

Cancer journal (Sudbury, Mass.)·2001
Same author

Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma.

American journal of clinical oncology·2001
Same author

The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy.

American journal of surgery·2000
Same author

Sonography of palpable breast cancer.

Journal of clinical ultrasound : JCU·2000
Same journal

Stafne Bone Cavity.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2018
Same journal

Mounier-Kuhn Syndrome.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2018
Same journal

Calcific Tendinitis of the Longus Colli Muscle.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2018
Same journal

Bronchial Atresia.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2018
Same journal

Food Impaction in a 9-Year-Old Boy.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2018
Same journal

Traumatic Intrapericardial Diaphragmatic Herniation.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2018
See all related articles

This review examines how recent technological improvements in ultrasound have transformed breast imaging, allowing for better detection, characterization, and treatment of breast diseases.

Area of Science:

  • Diagnostic imaging within breast sonography research
  • Medical oncology and interventional radiology

Background:

Medical professionals currently lack a comprehensive understanding of how modern ultrasound innovations have altered clinical breast care. Prior research has shown that early imaging tools provided limited resolution for small, nonpalpable masses. That uncertainty drove the development of advanced hardware to improve diagnostic accuracy. It was already known that traditional grayscale imaging often struggled to distinguish between benign and malignant tissue types. This gap motivated the integration of sophisticated signal processing and transducer designs into routine practice. No prior work had resolved the full impact of these diverse technical upgrades on patient staging. Researchers have since documented a shift toward more precise interventional guidance using these updated systems. The field now recognizes these tools as vital for managing complex breast pathologies effectively.

Purpose Of The Study:

The aim of this review is to evaluate the impact of recent technological developments on the clinical practice of breast sonography. This study addresses the need to understand how hardware and software innovations have matured over the last decade. The authors seek to clarify how these improvements influence the detection and characterization of breast masses. The motivation for this work stems from the rapid expansion of ultrasound applications in oncology. Researchers intend to demonstrate how higher-frequency transducers and advanced imaging modes provide better diagnostic clarity. The study also explores the shift toward using sonography for complex interventional procedures. By synthesizing current evidence, the authors aim to highlight the transition of ultrasound from a basic screening tool to a sophisticated guidance system. This work addresses the specific problem of distinguishing between benign and malignant diseases with greater reliability.

Keywords:
ultrasound technologycancer staginginterventional radiologytissue characterization

Frequently Asked Questions

The researchers propose that modern ultrasound systems improve tissue characterization and cancer staging by utilizing higher-frequency wideband transducers and harmonic imaging. These tools allow for more reliable differentiation between benign and malignant masses compared to older, lower-resolution grayscale methods.

The authors identify 2-D array phased-array technology and extended-field-of-view imaging as key components. These innovations enable clinicians to visualize larger areas with greater detail, facilitating the localization of nonpalpable masses that were previously difficult to detect.

According to the authors, high-sensitivity color and power Doppler imaging are necessary to assess vascularity within lesions. This technical requirement helps clinicians distinguish between different types of breast diseases, providing more diagnostic information than standard imaging alone.

Related Experiment Videos

Main Methods:

Review approach involved a systematic synthesis of recent technological advancements in ultrasound hardware and software. The authors evaluated literature regarding wideband transducer performance and phased-array signal processing capabilities. This analysis focused on how these tools influence the detection of nonpalpable breast masses. The review approach also examined clinical data related to contrast-enhanced imaging and harmonic signal acquisition. Researchers assessed the utility of these systems in differentiating benign from malignant tissue signatures. The study design incorporated findings from interventional radiology procedures, specifically percutaneous biopsies and needle-based localizations. The approach synthesized evidence on the integration of Doppler imaging for vascular assessment. Finally, the authors reviewed emerging literature on percutaneous ablation techniques like cryotherapy and radiofrequency.

Main Results:

Key findings from the literature demonstrate that technological maturity has enabled more reliable tissue characterization and differentiation between benign and malignant breast diseases. The review indicates that higher-frequency wideband transducers provide superior resolution for identifying small, nonpalpable masses. Results show that 2-D array phased-array technology improves the accuracy of staging for cancer patients. The literature highlights that sonography has become the preferred guidance technique for percutaneous needle biopsies. Evidence suggests that contrast agents and harmonic imaging significantly enhance the diagnostic utility of modern ultrasound systems. Findings reveal that clinicians can now localize calcifications that were previously invisible on standard imaging. The research notes that ultrasound-guided percutaneous ablation using cryotherapy or radiofrequency is a rapidly expanding area of clinical practice. Data confirms that these innovations have collectively broadened the applications of breast sonography in modern oncology.

Conclusions:

The authors propose that technological maturity in ultrasound has significantly enhanced clinical decision-making for breast cancer patients. Synthesis and implications suggest that higher-frequency transducers and advanced imaging modes provide superior tissue characterization compared to older methods. Evidence indicates that these improvements facilitate more reliable differentiation between benign and malignant disease states. The review highlights that sonography now serves as the primary guidance modality for various interventional procedures. Authors note that the ability to target nonpalpable masses has expanded the scope of minimally invasive care. Findings imply that contrast agents and harmonic imaging contribute to more accurate staging of oncological conditions. The researchers suggest that ultrasound-guided ablation techniques represent a promising frontier for treating specific breast lesions. Future clinical practice will likely rely on these integrated technologies to optimize patient outcomes and reduce surgical necessity.

The researchers explain that contrast agents play a significant role in enhancing image quality. By using these substances, clinicians can achieve better visualization of tissue characteristics, which assists in the accurate staging of cancer patients.

The authors report that sonography now serves as the guidance technique of choice for percutaneous needle biopsy. This measurement of success is compared to older, less precise methods that lacked the real-time visualization provided by current ultrasound systems.

The researchers propose that ultrasound-guided percutaneous ablation, utilizing cryotherapy or radiofrequency, represents a growing field. This implication suggests that sonography may move beyond diagnosis to become a primary tool for the minimally invasive treatment of specific breast lesions.